Successful treatment of relapsed acute B-cell lymphoblastic leukemia with CD20/CD22 bispecific chimeric antigen receptor T-cell therapy
Zuyu Liang,
Jiazhen Cui,
Alex Hongsheng Chang,
Jian Yu,
Yongxian Hu,
He Huang
Affiliations
Zuyu Liang
Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China; Hematology institute of Zhejiang University, Hangzhou, 310003, China
Jiazhen Cui
Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China; Hematology institute of Zhejiang University, Hangzhou, 310003, China
Alex Hongsheng Chang
Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
Jian Yu
Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China; Hematology Institute of Zhejiang University, Hangzhou, 310003, China
Yongxian Hu
Corresponding author. Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, No.79 Qingchun Road, Hangzhou, China. Fax: 86-0571-87236706; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China; Hematology Institute of Zhejiang University, Hangzhou, 310003, China
He Huang
Corresponding author. Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, No.79 Qingchun Road, Hangzhou, China. Fax: 86-0571-87236706; Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China; Hematology Institute of Zhejiang University, Hangzhou, 310003, China
